ALDH1A1 and neoplasm: These pre-clinical data were further supported by the analysis of double-marker immunofluorescence in human TNBC cases that allowed us to reveal the intra-tumor coexistence of neoplastic elements co-expressing both ALDH1A1 with PD-L1 and CD44v6 with PD-L1 biomarkers.